IDF-PAHO webinar: Diabetes care during the COVID-19 era in the IDF SACA region
27 January 2021
On February 9 (20:00 CET/14 :00 EST), IDF and the Panamerican Health Organization (PAHO) will host a webinar on the impact that COVID-19 has had on diabetes care in the IDF South and Central America (SACA) region.
WHO Executive Board adopts decision on addressing diabetes as public health concern
22 January 2021
On January 21, 2021, the WHO 148th Executive Board adopted a Decision on Addressing Diabetes as a Public Health Concern. The decision was proposed by Canada, Costa Rica, Eswatini, France, Indonesia, Jamaica, Norway, Qatar, the Russian Federation, Sudan, Uruguay and Vanuatu.
GCCH statement on oral health to the 148th WHO Executive Board
22 January 2021
On the occasion of the 148th WHO Executive Board (January 18-26), the Global Coalition for Circulatory Health (GCCH, which IDF is a member of) released a statement asking Member States to adopt the draft Resolution on Oral Health that was tabled for discussion. The Resolution was adopted on January 21.
IDF, GCCH and NCDA statement to the 148th WHO Executive Board
20 January 2021
The World Health Organization (WHO) is currently holding its 148th Executive Board from January 19 to 26. The agenda includes several NCD-related items, including the discussion of a Draft Decision on Addressing Diabetes as a Public Health Concern.
Global Coalition for Circulatory Health call to action on Universal Health Coverage
09 December 2020
The Global Coalition for Circulatory Health (GCCH), of which IDF is a member, has been calling on governments to do more to address the growing concern of cardiovascular diseases (including diabetes) since its creation in 2017. The urgent need to address cardiovascular diseases has become even more pressing this year as a result of the disproportionate impact the COVID-19 pandemic is having on people living with circulatory conditions such as diabetes, kidney disease or stroke.
Medicines Patent Pool mobilises leading generic drug makers to pledge for collective action against COVID-19
17 November 2020
As the COVID-19 pandemic intensifies, IDF partner Medicines Patent Pool (MPP) is mobilizing its network to encourage innovators developing new or re-purposed therapies to negotiate public health licensing agreements with MPP to allow for broader access to their know-how and intellectual property.
The Lancet publishes a new report calling for action to close the gap in diabetes prevention and care
13 November 2020
Ahead of World Diabetes Day on 14 November, The Lancet has published a new report calling for action to close the gap in diabetes prevention and care. Worldwide, 463 million people have diabetes, with 80% from low-income and middle- income countries (LMICs). In 2019, 4.2 million people died as a result of the condition and its complications.
Call to recognise multi-morbidity and co-morbidity as a growing public health concern
12 November 2020
On occasion of the resumed 73rd World Health Assembly on November 9-14, the Global Coalition for Circulatory Health has made a statement to agenda item A73/5, on the need for Member States to recognise the impact of COVID-19 on people with kidney disease, diabetes, stroke and other cardiovascular diseases. Many are facing the interruption of live-saving treatments due to the pandemic.
Last summer, WHO announced the launch in 2021 of a Global Diabetes Compact, a global partnership for local solutions to pave the way for universal access to health services and medicines to prevent, screen, diagnose and treat diabetes.
The International Diabetes Federation (IDF) is looking for testimonials on living with diabetes in the school environment. These testimonials will support the promotion of the Kids with Diabetes in Schools (KiDS) project on IDF online and social media channels.
The International Diabetes Federation was officially founded on September 23, 1950. From humble beginnings, with 16 countries as initial members, IDF has grown into a global organisation representing over 160 countries and territories and hundreds of millions of people affected by diabetes.
IDF joins forces with Medicines Patent Pool to improve access to diabetes medicines
10 August 2020
The International Diabetes Federation (IDF) has signed a Memorandum of Understanding (MoU) with the Medicines Patent Pool (MPP) to improve access to affordable and high-quality diabetes medicines in low- and middle-income countries (LMICs).
IDF partners with ITN Productions Industry News on news-style programme to be launched on World Diabetes Day
04 August 2020
The International Diabetes Federation is collaborating with ITN Productions Industry News on a news-style programme - "Diabetes Matters” - to raise the profile of diabetes and unite voices in diabetes awareness for World Diabetes Day 2020 and beyond.
73rd World Health Assembly: IDF supports WHF and Global Circulatory Health Coalition statement
18 May 2020
IDF has joined the Global Coalition for Circulatory Health in publishing a statement in support of the World Health Organization applauding their relentless commitment to science, solutions, and solidarity in fighting the COVID-19 pandemic.
IDF joins Global Coalition in urging US to reconsider WHO funding decision
07 May 2020
IDF has joined the Global Coalition for Circulatory Health in publishing a letter in support of the World Health Organization (WHO) and its Director-General, and requesting the US government to reconsider its decision to suspend funding to WHO.
COVID-19 is a new and potentially serious coronavirus. The World Health Organization (WHO) has declared the COVID-19 outbreak to be a public health emergency of international concern. Español | Français
New findings, published in the 9th Edition of the IDF Diabetes Atlas, show that there are now 463 million adults with diabetes worldwide. The new figures highlight the alarming growth in the prevalence of diabetes around the world.
Forcibly-displaced people with diabetes at higher risk of disability and early death
22 May 2018
The International Diabetes Federation (IDF) estimates that four million people living with diabetes are forcibly displaced as a result of man-made and natural disasters. In these difficult circumstances, people with diabetes often struggle to manage their condition and are at increased risk of disability and early death. In order to raise awareness of the challenges of preventing and managing diabetes in humanitarian settings, IDF has launched a multi-stakeholder initiative to encourage action, improve health services and ensure access to essential medicines for displaced people with diabetes.
Hypoglycaemia is a common and serious complication of diabetes, particularly affecting people with diabetes treated with insulin. Consisting of very low levels of blood glucose, hypoglycaemia can lead to cognitive decline, cardiovascular events and even death.
As much about hypoglycaemia remains unknown, the International Diabetes Federation (IDF) is participating in a new Research Project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes. IDF has joined forces with over 20 leading international players from academia, industry and civil society to find better solutions to alleviate the burden and consequences of this serious complication.
The importance of nutrition education to tackle diabetes
17 April 2018
On the occasion of the 71st World Health Assembly, IDF will hold a multi-stakeholder panel discussion on how quality nutrition education can be part of the solution to overcome the global health challenges posed by diabetes and obesity.
Latest issue of Diabetes Voice - Working together to tackle diabetes
05 April 2018
The April 2018 issue of Diabetes Voice is dedicated to the variety of ways in which IDF, its partners, and leaders in diabetes care and advocacy are working hard to improve the lives of all people connected to diabetes—locally, national and globally.
IDF and Lions Clubs International come together to tackle diabetes
24 March 2018
On Saturday, March 24, 2018, Lions Clubs International (LCI) and the International Diabetes Federation (IDF) signed a Memorandum of Understanding (MOU), on the occasion of Lions Day at the UN, to establish a cooperative alliance in the global fight against diabetes.
IDF and leading eye health organizations call for urgent action to address diabetic eye disease
13 December 2017
Every person with diabetes is at risk of going blind. Around 1 in 3 people with diabetes develop some form of eye health complication, which if left untreated can have devastating and wide ranging social and economic impacts on them, their families and communities.
Interim results of first-ever global survey show people with type 2 diabetes underestimated their cardiovascular risk
06 December 2017
The International Diabetes Federation (IDF) has presented the interim results of the first-ever multi-country online survey on CVD risk awareness and knowledge among people living with type 2 diabetes, indicating low levels of awareness and limited dialogue between patients and healthcare professionals.
New IDF figures show continued increase in diabetes across the globe, reiterating the need for urgent action
14 November 2017
To mark World Diabetes Day today, the International Diabetes Federation (IDF) has released new estimates on the prevalence of diabetes around the world, indicating that 1 in 11 adults are currently living with diabetes, 10 million more than in 2015.
IDF launches first ever global survey on CVD awareness among people with type 2 diabetes
29 September 2017
To mark World Heart Day, the International Diabetes Federation (IDF) has partnered with Novo Nordisk to launch the first ever multi-country online survey investigating the level of CVD awareness and knowledge among people living with type 2 diabetes.
Selected implementation sites for first round of BRIDGES 2 programme announced
14 September 2017
Novena University (Delta State, Nigeria), the College of Medicine of University of Nigeria (Nigeria) and the Universitas Syiah Kuala (Banda Aceh, Indonesia), in collaboration with Georg-August Universität Gottïngen in Germany, have been selected as implementation sites for the first round of the IDF BRIDGES 2 (Bringing Research in Diabetes to Global Environments and Systems) programme.
Each of the three institutions will receive funding and the adequate mentorship to implement a tailor-made diabetes secondary prevention programme. This will enable the implementation of established evidenced-based interventions and community oriented approaches to diabetes care in different settings, with the ultimate aim of improving health outcomes for people living with diabetes.
The selected projects are varied and include a randomized trial on the suitability of peer education to improve diabetes management and outcomes in a low-income setting (Banda Aceh, Indonesia); a randomized trial on an intensive education intervention using a mobile application and network of people living with diabetes to implement glycaemic control (Delta State, Nigeria); and a community-based randomized trial and lifestyle intervention using a targeted shared care approach on pregnancy outcomes in Nigerian women with gestational diabetes but without diabetes (Nsukka, Nigeria).
Robert Gabbay, Chair of the BRIDGES 2 Steering Group, said: “Following a detailed peer review process by a group of cross disciplinary international experts in diabetes and global health, we have selected these three projects to disseminate the successful approaches from our previously funded BRIDGES 1 projects”.
BRIDGES 2 is a joint programme of the International Diabetes Federation (IDF) and Eli Lilly and Company (Lilly).
Around 90% of people with diabetes have type 2 diabetes. From the onset of the disease until the symptoms develop, many people with undiagnosed diabetes already have complications such as chronic kidney disease, heart failure, retinopathy and neuropathy. Early detection, diagnosis, and cost-effective treatments can save lives and prevent or significantly delay devastating diabetes-related complications.
Latest issue of Diabetes Voice focuses on improving access to diabetes care
05 July 2017
In the July issue of Diabetes Voice, we turn our attention to the problem many people with diabetes face in accessing essential care and medicine across the globe. Diabetes is life-long and its management can be costly both for people with diabetes and national health systems.
IDF launches Clinical Practice Recommendations on the Diabetic Foot
19 June 2017
The diabetic foot is one of the most serious and costly complications of diabetes, resulting in an important economic, social, and public health burden, particularly in low-income communities. With the growing number of people living with diabetes worldwide, healthcare professionals are encouraged to pay attention to the major complications of diabetes in their daily practice.
IDF and Lilly announce second phase of BRIDGES programme
09 June 2017
More than 400 million people are living with diabetes. In a further effort to help spread lessons learned from clinical research to benefit people affected by this condition, the International Diabetes Federation (IDF) and Eli Lilly and Company (Lilly) have come together for the second phase of the Bringing Research in Diabetes to Global Environments and Systems programme (BRIDGES 2), reaffirming their commitment to helping people with diabetes effectively manage their condition.
IDF highlights access to care as a leading concern of people with diabetes
24 May 2017
On the occasion of the 70th World Health Assembly, the International Diabetes Federation (IDF) held a panel discussion in Geneva between people with diabetes and healthcare professionals on priority solutions to overcome national gaps between provision and availability of diabetes care and treatment among underserved populations.
IDF launches IDF School of Diabetes Certified Courses for Health Professionals
19 May 2017
The International Diabetes Federation (IDF) recognises the value of providing continued professional education for health professionals and resources for people with diabetes and caregiver in a sustainable and convenient manner. To this end, IDF is pleased to announce the launch of the IDF School of Diabetes Certified Courses, a set of online courses tailored to the needs of a variety of healthcare professionals.
World Diabetes Day 2017 to focus on women and diabetes
08 March 2017
To mark International Women's Day on March 8, the International Diabetes Federation (IDF) is pleased to announce that the theme of World Diabetes Day 2017 will be Women and diabetes - Our right to a healthy future.